Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial.
Stadler R, Luger T, Bieber T, Köhler U, Linse R, Technau K, Schubert R, Schroth K, Vakilzadeh F, Volkenandt M, Gollnick H, Von Eick H, Thoren F, Strannegård O. Stadler R, et al. Acta Oncol. 2006;45(4):389-99. doi: 10.1080/02841860600630954. Acta Oncol. 2006. PMID: 16760174 Clinical Trial.
[Underutilization of anticancer agents--an example].
Strannegård O, Thorén FB. Strannegård O, et al. Among authors: thoren fb. Lakartidningen. 2010 Dec 8-14;107(49):3150; discussion 3150-1. Lakartidningen. 2010. PMID: 21280349 Swedish. No abstract available.
[The discussion about Multiferon should go on].
Strannegård O, Thorén FB. Strannegård O, et al. Among authors: thoren fb. Lakartidningen. 2010 Dec 15-21;107(50):3227; discussion 3227. Lakartidningen. 2010. PMID: 21294341 Swedish. No abstract available.
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
Dandona P, Mathieu C, Phillip M, Hansen L, Griffen SC, Tschöpe D, Thorén F, Xu J, Langkilde AM; DEPICT-1 Investigators. Dandona P, et al. Lancet Diabetes Endocrinol. 2017 Nov;5(11):864-876. doi: 10.1016/S2213-8587(17)30308-X. Epub 2017 Sep 14. Lancet Diabetes Endocrinol. 2017. PMID: 28919061 Clinical Trial.
58 results